Dr. Gordon T. Sakamoto

Dr. Mitchel S. Berger is a nationally recognized expert in treating brain and spinal cord tumors as well as tumor-related epilepsy in adults and children. He also is a specialist in brain mapping techniques – used to identify and preserve areas of motor, sensory and language function during surgery – and an expert in using the Gamma Knife, a precise, noninvasive tool that applies radiation beams for tumor treatment. He is director of the Brain Tumor Center, director of the Center for Neurological Injury and Repair and co-director of the Adult Brain Tumor Surgery Program. Berger earned his bachelor's degree from Harvard College in 1975 and his medical degree from the University of Miami Miller School of Medicine in 1979. He completed an internship and a residency at UCSF, and was awarded a clinical fellowship in neuro-oncology by the American Cancer Society and a research fellowship by the Brain Tumor Research Center. He completed further fellowship training in neuro-oncology at UCSF and in pediatric neurosurgery at the Hospital for Sick Children, an affiliate of the University of Toronto. Berger was elected to the American Association of Neurological Surgeons' board of directors and appointed to the American Board of Neurological Surgery. Dr. Berger is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, Awake Craniotomy, and Endovascular Embolization. Dr. Berger is board certified in Neurological Surgery and American Board Of Neurological Surgery, Neurological Surgery. Dr. Berger is currently accepting new patients.

Dr. Jennie Taylor specializes in caring for adults with primary brain tumors, or tumors that start in the brain. As a member of the UCSF Brain Tumor Research Center, she is involved in developing new treatment strategies, innovative imaging techniques and comprehensive tumor analyses, with the goal of improving outcomes for patients with brain tumors. Taylor's research interests include analyzing molecular and imaging markers of resistance to current standard treatments for brain tumors. She also focuses on improving quality of life for patients with primary brain tumors as well as for their caregivers. Taylor earned her medical degree from the University of Kentucky College of Medicine. She completed an internship in medicine and a residency in neurology at the University of Virginia. She completed a fellowship in neuro-oncology at Massachusetts General Hospital and the Dana-Farber Cancer Institute while earning a master's degree in public health from the Harvard T.H. Chan School of Public Health. Taylor is a member of the American Academy of Neurology, Society for Neuro-Oncology and American Society of Clinical Oncology. Dr. Taylor is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Taylor is board certified in American Board Of Psychiatry/Neurology-Neurology, Neurology. Dr. Taylor is currently accepting new patients.

Dr. Philip Starr is a neurosurgeon with interests in stereotactic and functional neurosurgery; surgical treatment of movement disorders, such as Parkinson's disease; and the physiology of the basal ganglia (brain neurons involved in vital functions, including motor control). He finds improving the quality of patients' lives to be the greatest reward in his specialty. Starr earned his medical degree from Harvard Medical School and completed a residency in neurosurgery at Brigham and Women's Hospital. He completed a fellowship in surgery for movement disorders at Emory University Hospital. Starr is a member of the American Society for Stereotactic and Functional Neurosurgery. Dr. Starr is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, Deep Brain Stimulation, and Thalamotomy. Dr. Starr is board certified in American Board Of Neurological Surgery, Neurological Surgery. Dr. Starr is currently accepting new patients.